Data / Form D filings / GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc.: Form D filings
GeneCentric Therapeutics, Inc., a biotechnology company in Durham, NC, filed 8 Form D notices with the SEC between 2011 and 2025. The latest, on June 20, 2025, reports $2 million sold of a $5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 CAPITOLA DRIVE, SUITE 275, Durham, NC, 27713
- Phone
- (919) 973-6544
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1529224
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | New notice | $5,000,000 | $1,999,967 | $3,000,033 | 9 | Jun 4, 2025 | sec.gov |
| Sep 20, 2022 | New notice | $3,500,000 | $2,500,000 | $1,000,000 | 1 | Sep 8, 2022 | sec.gov |
| Oct 7, 2021 | New notice | $7,500,000 | $4,500,000 | $3,000,000 | 1 | Sep 22, 2021 | sec.gov |
| Jan 13, 2021 | New notice | $1,200,000 | $1,200,000 | 4 | Dec 29, 2020 | sec.gov | |
| Jan 5, 2017 | New notice | $8,605,992 | $6,105,996 | $2,499,996 | 4 | Dec 22, 2016 | sec.gov |
| Jul 11, 2014 | Amendment | $5,000,010 | $5,000,010 | 4 | Jun 19, 2013 | sec.gov | |
| Jul 2, 2013 | New notice | $5,000,010 | $2,500,005 | $2,500,005 | 4 | Jun 19, 2013 | sec.gov |
| Sep 16, 2011 | New notice | $250,000 | $250,000 | 2 | Sep 2, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CLAY THORP | Director | |
| MICHAEL MILBURN | Executive Officer, Director | |
| ARNOLD LEVINE | Director | |
| CHARLES PEROU | Director | |
| Prasanth Reddy | Director | |
| MYLA LAI-GOLDMAN | Director | |
| Don Hardison | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 16, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GeneCentric Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.